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As part of a detailed search of the C. elegans genome
sequence for putative DNA repair genes, we identified a
putative ortholog of BARD1 (K04C2.4, Ce-brd-1; FigureSummary
1A). K04C2.4 encodes a protein (Ce-BRD-1) of 670
amino acids with 23% identity and 41% similarity toInherited germline mutations in the tumor suppressor
human BARD1. Containing a putative N-terminal RINGgene BRCA1 predispose individuals to early onset
finger domain, three ankyrin repeats in the central regionbreast and ovarian cancer [1]. BRCA1 together with
of the protein, and two C-terminal BRCT repeat do-its structurally related partner BARD1 is required for
mains, Ce-BRD-1 is most related to Xenopus laevishomologous recombination and DNA double-strand
BARD1 (Figure 1A) [16]. Given that BRCA1 occurs as abreak repair, but how they perform these functions
heterodimer with BARD1, the identification of Ce-BRD-1remains elusive [2, 3]. As part of a comprehensive
raised the possibility that a BRCA1 homolog may alsosearch for DNA repair genes in C. elegans, we identi-
exist in the nematode. However, extensive sequencefied a BARD1 ortholog. In protein interaction screens,
searches of the C. elegans genome failed to uncover aCe-BRD-1 was found to interact with components of
potential BRCA1 homolog.the sumoylation pathway, the TACC domain protein
To identify a Ce-BRD-1 partner that may perform aTAC-1, and most importantly, a homolog of mamma-
function analogous to that of BRCA1, we screened forlian BRCA1. We show that animals depleted for either
Ce-BRD-1-associated proteins by using the yeast two-Ce-brc-1 or Ce-brd-1 display similar abnormalities, in-
hybrid system [17]. Among the Ce-BRD-1-interactingcluding a high incidence of males, elevated levels of
proteins identified were the ubiquitin-like SMT-3/sumop53-dependent germ cell death before and after irradi-
protein, the E2 sumo-conjugating enzyme UBC-9, andation, and impaired progeny survival and chromosome
a protein of unknown function (TAC-1; Y54E2A.3) thatfragmentation after irradiation. Furthermore, deple-
contains a TACC domain also present in AZU1, a puta-tion of ubc-9 and tac-1 leads to radiation sensitivity
tive breast cancer tumor suppressor (see the Supple-and a high incidence of males, respectively, potentially
mental Data available with this article online) [18]. Mostlinking these genes to the C. elegans BRCA1 pathway.
importantly, we identified Ce-BRC-1 (C36A4.8), a proteinOur findings support a shared role for Ce-BRC-1 and
of 596 amino acids that is 24% identical and 52% similarCe-BRD-1 in C. elegans DNA repair processes, and
to the major human BRCA1 delta-exon 11 splice variant.this role will permit studies of the BRCA1 pathway in an
Similar to BRCA1, Ce-BRC-1 contains an N-terminalorganism amenable to rapid genetic and biochemical
RING finger, a nuclear localization signal, and twoanalysis.
C-terminal BRCT repeat domains (Figure 1B). Ce-BRC-1
was missed in bioinformatic searches of the C. elegans
Results genome because of an error by the Genefinder program,
which failed to predict three of its exons (Figure 1B).
A host of reports have implicated BRCA1 in DNA repair To confirm the Ce-BRD-1 interactions with Ce-BRC-1,
processes, a function that may partly explain its role as UBC-9, and SMT-3, we used yeast two-hybrid matrix
a tumor suppressor [1, 4, 5]. BRCA1 was found to inter- and in vitro pull-down assays. Our results suggest that
act with Rad51 and form foci at sites of DNA double Ce-BRC-1 and Ce-BRD-1, similar to their mammalian
counterparts [11, 12], interact with each other through
their RING domains located at their respective N-termini;*Correspondence: simon.boulton@cancer.org.uk
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Figure 1. Gene and Domain Structure of Ce-BRC-1 and Ce-BRD-1 and Their Relationship to BRCA1 and BARD1
(A) The gene structure of Ce-brd-1 (K04C2.4). The upper panel shows a comparison of the predicted intron-exon gene structure (white boxes,
exons) of the Ce-brd-1-coding locus compared with the confirmed gene struI¨ture (black boxes, exons) derived from ORFeome sequencing.
Ce-BRD-1 encodes a 670 amino acid protein with a putative RING finger (red), three ankyrin repeats (green), and two BRCT domains (blue)
and is highly related to hsBARD1. Shown in the lower panel is the protein sequence alignment between Ce-BRD-1 and X. lavis BARD1
(xlBARD). The key for colors is as for the domain structure.
(B) The corrected gene structure of Ce-brc-1 (C36A4.8). Note the three additional, confirmed exons (black) not found in the predicted gene
structure (white). Ce-BRC-1 encodes a 596 amino acid protein with a RING finger (red) and two BRCT domains (blue). Shown in the lower
panel is the protein sequence alignment between Ce-BRC-1 and hsBRCA1 delta exon 11 (hsbrca1_ex). The key for colors is as for the domain
structure.
the N-terminal 130 amino acids of Ce-BRC-1 and Ce- combination through their ability to interact with UBC-9
(Figure 2D and Supplemental Data).BRD-1 are sufficient for heterodimerization but do not
interact with themselves (Figure 2A). Furthermore, full- To investigate if Ce-BRC-1 and Ce-BRD-1 participate
in C. elegans damage response pathways, we depletedlength Ce-BRC-1 and the N-terminal region of Ce-BRC-1
fused to glutathione S-transferase (GST) can efficiently them by using RNA-mediated interference (RNAi) via the
RNAi feeding procedure [20, 21]. Under normal growthpull-down the corresponding N-terminal region of Ce-
BRD-1 expressed in vitro (Figure 2B, lanes 2 and 3). Our conditions, depletion of Ce-brc-1 or Ce-brd-1 gave rise
to elevated levels of chromosome nondisjunction thatresults imply that this interaction is conserved and sug-
gest that Ce-BRC-1 and Ce-BRD-1 may function to- manifest as a high proportion of males (Him phenotype;
the result of X chromosome nondisjunction) in the selfgether as a heterodimer in C. elegans but are unlikely
to function separately as homodimers. We also found progeny. Consistent with a weak Him phenotype, we
observed 2.54% (17/670) and 2.88% (23/798) males forthat UBC-9 could efficiently interact with the DNA
strand-exchange protein RAD-51 and Ce-BRD-1 in both Ce-brc-1- and Ce-brd-1-depleted animals, respectively,
in contrast to 0.13% (1/756) males for the RNAi control.the yeast two-hybrid system and in pull-down experi-
ments from tissue culture cells (Figures 2C and 2D, lanes Ce-brc-1- and Ce-brd-1-depleted animals also dis-
played elevated levels of germ cell death under normal1 and 4, respectively). Experiments in human cells have
shown that BRCA1 can associate with RAD51 in GST growth conditions (Figure 3A, panels 2, 3, 8, and 9).
Using CED-1::GFP as a marker of germ cell deathpull downs [19]. Our results suggest that the Ce-BRC-1/
Ce-BRD-1 heterodimer may associate indirectly with showed the number of corpses in Ce-brc-1 and Ce-
brd-1 RNAi animals to be 8.2  3.1 (n  50) and 9.4 RAD-51 and other proteins involved in homologous re-
BRCA1/BARD1 Are Functionally Conserved in C. elegans
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Figure 2. Ce-BRD-1-Interacting Proteins
(A) Ce-BRD-1 and Ce-BRC-1 interact through their respective N-terminal domains. We used the yeast two-hybrid system to test for protein
interactions between full-length, N-terminal (amino acids 1–130), and C-terminal (Ce-BRC-1: amino acids 130–602; Ce-BRD-1: amino acids
130–653) fused to either the DNA binding domain (DB) or the activation domain (AD) of GAL4 by scoring for lacZ expression and growth on
20 mM 3AT plates.
(B) GST fusions to full-length (lane 2), N-terminal (lane 3), and C-terminal (lane 4) fragments of Ce-BRC-1 were used to pull down an N-terminal
Ce-BRD-1 fragment expressed in vitro.
(C) The yeast two-hybrid system was used to test for protein interactions among Ce-BRC-1, Ce-BRD-1, UBC-9, SMT-3,and RAD-51 fused to
either the DNA binding domain (DB) or the activation domain (AD) of GAL4.
(D) Myc-tagged UBC-9 was used to pull down 6xHis-tagged Ce-BRD-1 and 6xHis-tagged RAD-51 expressed in 293T cells.
3.8 (n  50) per germline, respectively. In contrast, an in cep-1 (C. elegans p53) and rad-5 checkpoint mutants
depleted of Ce-brc-1 and Ce-brd-1 [22–24]. Both cep-1average of 1.2  0.5 (n  50) corpses were observed in
the wild-type germline under normal growth conditions. and rad-5 mutations were found to suppress the ele-
vated number of apoptotic corpses in Ce-brc-1 or Ce-Exposure of Ce-brc-1- and Ce-brd-1-depleted ani-
mals to -irradiation at the late L4 stage resulted in brd-1 RNAi animals before and after irradiation (Figure
4A). These results demonstrate that the enhanced apo-dramatically enhanced levels of germ cell death that
became evident at the 4 hour time point after irradiation ptotic phenotype observed in Ce-brc-1- and Ce-brd-
1-depleted animals, both before and after exposure to(Figure 3A: panels 5, 6, 11, and 12; Figure 3B) and
reached a maximum at the 24 hour time point (Figure -irradiation, requires an intact DNA damage check-
point.3A: panels 14 and 15; Figure 3B and data not shown).
At the latter time point, oocytes were absent, and the To analyze chromosome integrity after irradiation of
Ce-brc-1- or Ce-brd-1-depleted animals, we used DAPIgeneral morphology of the germline was severely com-
promised because of extensive germ cell death (Figure staining to visualize germline nuclei after treatment of
late L4 stage animals with -irradiation. In contrast to3A, panels 14 and 15). The hatching rates of progeny
from both Ce-brc-1- and Ce-brd-1-depleted animals controls, germlines isolated from irradiated Ce-brc-1-
or Ce-brd-1-depleted animals displayed evidence of ab-were found to be dramatically reduced after exposure
to -irradiation when these animals were compared to normal chromosome morphology and fragmentation in
transition zone and pachytene nuclei (Figure 4B). Chro-RNAi controls (Figure 3C), demonstrating that Ce-brc-1-
and Ce-brd-1-depleted animals are radiation sensitive. mosomes appeared brittle and frayed, and in many nu-
clei small DNA fragments could be seen broken off fromTo test if the apoptotic phenotype of Ce-brc-1- and
Ce-brd-1-depleted animals observed before and after the main body of chromatin (Figure 4B, panels 3–6).
Similar to RNAi of Ce-brc-1- and Ce-brd-1-depletedDNA damage is dependent on an intact DNA damage
checkpoint, we used RNAi to measure germ cell corpses worms, RNAi of tac-1 (Y54E2A.3) also gave rise to a Him
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Figure 3. Phenotypes of Ce-brc-1- and Ce-brd-1-Depleted Animals after Treatment with DNA-Damaging Agents
(A) Enhanced radiation induced death after depletion of Ce-brc-1 or Ce-brd-1. Shown is a representative image of the meiotic pachytene
region of RNAi-treated animals ( 75 Gy -irradiation) at the indicated time points after irradiation. Apoptotic corpses in the pachytene region
of the germline were visualized in CED-1::GFP transgenic animals as a ring of GFP fluorescence surrounding dying cells (panels 1–6) or as
refractile bodies seen under Nomaski optics (panels 7–15). The number of apoptotic corpses is indicated in the bottom left corner of panels
1–6. Panel numbers are indicated in the top right corner of each image.
(B) Apoptotic corpses were counted at 4, 12, and 24 hours after irradiation (75 Gy) in 20 animals for each data point. Error bars indicate SEM.
(standard error of the mean).
(C) Shown is the percent survival of progeny after exposure to the indicated doses of -irradiation. Error bars indicate SEM. Wild-type 
black; Ce-brc-1(RNAi)  green; Ce-brd-1(RNAi)  red.
phenotype (4.26% males [38/892]; see Supplemental importance of these findings is underscored by the ab-
Data), raising the possibility that Ce-BRC-1, Ce-BRD-1, sence of BRCA1/BARD1 homologs in fungus and fruit
and TAC-1 may function in a common pathway. Consis- fly genomes. Ce-brd-1 encodes a protein with amino
tent with a requirement for sumoylation in many biologi- acid identity and size similar to that of BARD1. However,
cal processes, RNAi of the sumo-conjugating enzyme Ce-brc-1 encodes a more divergent protein that is signif-
ubc-9 resulted in a pleiotropic phenotype that included icantly shorter than BRCA1 but is most related to its
sterility and embryonic lethality under normal growth exon delta 11 splice variant. The fact that sequences
conditions. After -irradiation, ubc-9-depleted animals resembling BRCA1 exon 11 are absent from the C. ele-
also displayed enhanced germ cell death, demonstra- gans genome raises the possibility that some functions
ting that ubc-9(RNAi) animals have radiation sensitivity of human BRCA1 may not be performed by either Ce-
similar to that of Ce-brc-1- and Ce-brd-1-depleted ani- BRC-1 or related factors in trans.
mals (see Supplemental Data). Our analyses suggest that Ce-brc-1 and Ce-brd-1
function together in a common DNA repair pathway,
consistent with the role of BRCA1 and BARD1 in mam-Discussion
malian cells. First, we demonstrate that Ce-BRC-1 and
Ce-BRD-1 physically interact in vitro via conserved do-The results presented here reveal the unanticipated dis-
mains that are also responsible for mediating the humancovery of functional orthologs of the BRCA1 tumor sup-
pressor gene and its partner BARD1 in C. elegans. The BRCA1-BARD1 interaction [12, 25]. Second, Ce-brc-1-
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Figure 4. Checkpoint-Dependent Apoptosis and Chromosomal Fragmentation in Ce-brc-1- and Ce-brd-1-Depleted Animals
(A) Enhanced germ cell death in the absence of Ce-brc-1 or Ce-brd-1 before and after irradiation is checkpoint dependent. Apoptotic corpses
before (white bars) and after (black bars) -irradiation were counted in wild-type N2, cep-1(gk138) and rad-5(mn159) mutants after RNAi
depletion with control, Ce-brc-1, and Ce-brd-1 RNAi constructs. In both cases, cep-1(gk138) and rad-5(mn159) suppressed the number of
apoptotic corpses after Ce-brc-1 and Ce-brd-1 RNAi to near wild-type levels. Twenty germlines were scored for each data point.
(B) IR-induced chromosomal defects in the absence of Ce-brc-1 or Ce-brd-1. L4 larval stage control, Ce-brc-1, and Ce-brd-1 RNAi animals
were treated with 20 Gy of -irradiation. Shown are two representative images of DAPI-stained germline nuclei in control (panels 1 and 2),
Ce-brc-1 (panels 3 and 4), or Ce-brd-1 (panels 5 and 6) RNAi animals 16 hrs after treatment. Chromosomes in Ce-brc-1- or Ce-brd-1-depleted
animals (panels 3–6) have an abnormal frayed appearance, and DNA fragments that are physically distinct from the main body of DAPI-stained
chromatin are apparent (arrows). Chromosomal abnormalities or DNA fragments were observed in individual nuclei at the following frequencies:
control RNAi (3/228); Ce-brc-1 (32/204); and Ce-brd-1 (47/263).
and Ce-brd-1-depleted animals display very similar phe- that these genes function together or regulate a common
pathway. Indeed, a Ce-BRC-1/Ce-BRD-1/UBC-9 com-notypes that are highly reminiscent of the phenotype of
human cells lacking BRCA1 [2]. We find that Ce-brc-1- plex could function in DNA repair processes by ubiqui-
tylating/sumoylating common targets required for DNAand Ce-brd-1-depleted animals gave rise to a Him phe-
notype (increased levels of X-chromosome non-disjunc- repair processes. Such posttranslational modifications
could be important for modulating the activities of repairtion) that could be caused by a defect during meiotic
prophase or by a premeiotic chromosome segregation proteins at the sites of DNA damage, as has been de-
scribed recently for budding yeast PCNA [26].defect. Cytological analysis of Ce-brc-1- and Ce-brd-
1-depleted animals failed to unambiguously identify the In summary, the existence of BRCA1 and BARD1 or-
thologs in C. elegans, an organism amenable to high-defect(s) responsible for this phenotype, suggesting that
a detailed study of loss-of-function mutants in Ce-brc-1 throughput genetic manipulation via genome-wide RNAi
libraries [38, 39], together with the observation that otherand Ce-brd-1 genes will be required to reconcile this
phenotype. Under normal growth conditions, we also BRCA1 pathway components, including orthologs of
FANCD2 and BACH1 ([27]; S.B., J.M., and J.P., unpub-observed increased checkpoint-dependent germ cell
death after depletion of Ce-brc-1 or Ce-brd-1. This sug- lished data), are conserved in C. elegans, suggests that
genetic and biochemical dissection of the BRCA1/gests that unrepaired DNA damage or aberrant chromo-
some structures that lead to checkpoint activation accu- BARD1 pathway in the nematode will lead to important
insights into its role in human disease.mulate after Ce-brc-1 or Ce-brd-1 depletion. Finally, we
show that treatment of Ce-brc-1- or Ce-brd-1-depleted
Experimental Proceduresanimals with -irradiation results in increased germ cell
death, radiation sensitivity, and chromosome fragmen-
Worm Strainstation. Together, these phenotypes strongly suggest
C. elegans strains were cultured as described previously [29]. The
that Ce-BRC-1 and Ce-BRD-1 are required for DNA re- following strains were kindly provided by the Caenorhabditis Genet-
pair in C. elegans. ics Center (University of Minnesota, St. Paul, MN): wild-type Bristol
N2, cep-1(gk138), a deletion in the C. elegans homolog of p53, andSMT-3, UBC-9, and TAC-1 were also identified as Ce-
SP506 rad-5(mn159). MD701 bcls39 V [Plim-7::CED-1::GFP] wasBRD-1-interacting proteins. We have shown that ubc-9
kindly provided by Barbara Conradt.and tac-1 RNAi depletion results in radiation sensitivity
and a Him phenotype, respectively (see Supplemental
Sequence AlignmentsData). Although further analysis will be required to con-
Protein sequences were aligned by pileup and refined via the lineup
clusively demonstrate both a physical and a genetic link algorithm (Genetics Computer Group). Mutiple sequence files were
among Ce-BRC-1/Ce-BRD-1, TAC-1, and components exported to ESPript 2.0 at http://prodes.toulouse.inra.fr/ESPript/
cgi-bin/nph-ESPript_exe.cgi for box-shading analysis.of the sumoylation pathway, it is tempting to speculate
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Gateway Recombinational Cloning Supplemental Data
Supplemental Data are available with this article online at http://ORF-specific primers compatible with the Gateway system [30, 31]
were designed to full-length Genefinder ORF predictions and cloned www.current-biology.com/cgi/content.full/14/1/33/DC1/.
into Entry as previously described. Primer sequences for cloning
K04C2.4 (Ce-brd-1) can be found at http://worfdb.dfci.harvard.edu/ Acknowledgments
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